Structures by: Gerhardt V.
Total: 35
6-Aminoisocytosine--<i>N</i>-methylpyrrolidin-2-one (1/1)
C4H6N4O,C5H9NO
Acta Crystallographica Section C (2015) 71, 9
a=8.1456(5)Å b=9.2289(6)Å c=14.9731(9)Å
α=90.00° β=96.463(5)° γ=90.00°
6-Aminoisocytosine--2,6-dichloroaniline--<i>N</i>,<i>N</i>-dimethylacetamide
C6H5Cl2N,C4H6N4O,C4H9NO
Acta Crystallographica Section C (2015) 71, 9
a=8.1060(5)Å b=9.0448(5)Å c=12.5656(8)Å
α=90.00° β=102.859(5)° γ=90.00°
2,4-Diamino-6-methyl-1,3,5-triazine--<i>N</i>,<i>N</i>-dimethylacetamide (1/1)
C4H7N5,C4H9NO
Acta Crystallographica Section C (2015) 71, 9
a=23.198(3)Å b=26.327(3)Å c=7.2880(10)Å
α=90.00° β=90.00° γ=90.00°
2,4-Diamino-6-methyl-1,3,5-triazine--2,6-dichlorophenol (1/1)
C6H4Cl2O,C4H7N5
Acta Crystallographica Section C (2015) 71, 9
a=5.0318(7)Å b=8.5779(11)Å c=15.008(2)Å
α=93.929(11)° β=96.214(11)° γ=100.121(11)°
2,4-Diamino-6-methyl-1,3,5-triazine--<i>N</i>-methylpyrrolidin-2-one (1/1)
C4H7N5,C5H9NO
Acta Crystallographica Section C (2015) 71, 9
a=23.178(2)Å b=26.3327(17)Å c=7.3428(5)Å
α=90.00° β=90.00° γ=90.00°
(2-aminopyridin-1-ium 2-amino-6-chloro-4-oxo-4<i>H</i>-pyrimidin-3-ide)--[2-amino-6-chloropyrimidin-4(3<i>H</i>)-one] (1/3)
C5H7N2,C4H3ClN3O,3(C4H4ClN3O)
Acta Crystallographica Section C (2016) 72, 1 84-93
a=10.8229(11)Å b=11.7395(14)Å c=12.7637(13)Å
α=62.633(8)° β=70.877(8)° γ=81.182(9)°
2-amino-5-bromo-6-methylpyrimidin-4(3<i>H</i>)-one--2-amino-5-bromo-6-methylpyrimidin-4(1<i>H</i>)-one (1/1)
C5H6BrN3O
Acta Crystallographica Section C (2016) 72, 1 84-93
a=9.8154(13)Å b=9.9532(8)Å c=14.344(2)Å
α=90° β=108.021(11)° γ=90°
2-amino-5-bromo-6-methylpyrimidin-4(3<i>H</i>)-one--2-amino-5-bromo-6-methylpyrimidin-4(1<i>H</i>)-one <i>N</i>-methylpyrrolidin-2-one monosolvate (1/1/1)
2(C5H6BrN3O),C5H9NO
Acta Crystallographica Section C (2016) 72, 1 84-93
a=11.7075(14)Å b=14.0308(11)Å c=11.8308(14)Å
α=90° β=103.096(10)° γ=90°
Bis-(2-aminopyridin-1-ium 2-amino-6-chloro-4-oxo-4<i>H</i>-pyrimidin-3-ide)--[2-amino-6-chloropyrimidin-4(3<i>H</i>)-one]--2-aminopyridine (2/10/1)
2(C5H7N2),2(C4H3ClN3O),10(C4H4ClN3O),C5H6N2
Acta Crystallographica Section C (2016) 72, 1 84-93
a=14.0097(7)Å b=14.0185(7)Å c=21.4229(11)Å
α=83.774(4)° β=84.000(4)° γ=83.554(4)°
2-amino-5-bromo-6-methylpyrimidin-4(3<i>H</i>)-one--2-amino-5-bromo-6-methylpyrimidin-4(1<i>H</i>)-one--2-amino-6-chloropyrimidin-4(3<i>H</i>)-one (0.635/1/0.365)
C4.64H5.27Br0.64Cl0.37N3O,C5H6BrN3O
Acta Crystallographica Section C (2016) 72, 1 84-93
a=9.270(5)Å b=11.423(4)Å c=12.559(7)Å
α=90° β=98.61(4)° γ=90°
C3H6N6,2(C5H9NO),H2O
C3H6N6,2(C5H9NO),H2O
Acta Crystallographica Section B (2015) 71, 2 209-220
a=7.6291(4)Å b=21.0118(8)Å c=10.9690(6)Å
α=90.00° β=98.950(4)° γ=90.00°
C4H3ClN2O2,C4H7N5,2(C5H9NO),H2O
C4H3ClN2O2,C4H7N5,2(C5H9NO),H2O
Acta Crystallographica Section B (2015) 71, 2 209-220
a=9.4450(6)Å b=10.3974(7)Å c=13.3661(8)Å
α=77.188(5)° β=89.846(5)° γ=67.043(5)°
C4H3ClN2O2,C4H7N5,C4H9NO
C4H3ClN2O2,C4H7N5,C4H9NO
Acta Crystallographica Section B (2015) 71, 2 209-220
a=6.9970(5)Å b=8.6140(5)Å c=13.8513(9)Å
α=85.725(5)° β=84.516(5)° γ=75.572(5)°
C4H3ClN2O2,C4H7N5,C3H7NO,H2O
C4H3ClN2O2,C4H7N5,C3H7NO,H2O
Acta Crystallographica Section B (2015) 71, 2 209-220
a=7.1719(11)Å b=8.6197(11)Å c=13.5029(19)Å
α=94.574(11)° β=92.707(12)° γ=99.840(11)°
C4H3ClN2O2,C3H4ClN5,C3H7NO
C4H3ClN2O2,C3H4ClN5,C3H7NO
Acta Crystallographica Section B (2015) 71, 2 209-220
a=8.4573(10)Å b=9.3488(10)Å c=10.8269(11)Å
α=72.144(8)° β=77.879(9)° γ=77.444(9)°
C4H3ClN2O2,C3H4ClN5,C3H7NO
C4H3ClN2O2,C3H4ClN5,C3H7NO
Acta Crystallographica Section B (2015) 71, 2 209-220
a=11.9691(7)Å b=12.3455(7)Å c=12.4618(7)Å
α=109.385(4)° β=96.199(5)° γ=111.598(4)°
C5H5ClN2O2,2(C3H6N6),C4H9NO,C2H7N,3(HCl)
C5H5ClN2O2,2(C3H6N6),C4H9NO,C2H7N,3(HCl)
Acta Crystallographica Section B (2015) 71, 2 209-220
a=18.6341(15)Å b=13.0507(10)Å c=12.3166(10)Å
α=90.00° β=101.365(7)° γ=90.00°
C5H5ClN2O2
C5H5ClN2O2
Acta Crystallographica Section B (2015) 71, 2 209-220
a=4.4135(6)Å b=15.780(3)Å c=9.0645(14)Å
α=90.00° β=92.025(12)° γ=90.00°
2,6-diaminopyrimidin-4-one
C4H6N4O
Acta Crystallographica Section C (2011) 67, 5 o179-o187
a=7.7150(9)Å b=9.7229(7)Å c=7.4514(8)Å
α=90.00° β=114.453(8)° γ=90.00°
2-amino-6-methylpyrimidin-4(3<i>H</i>)-one—–2-amino-6-methylpyrimidin-\ 4(1<i>H</i>)-one—–dimethylacetamide (1/1/1)
2(C5H7N3O),C4H9NO
Acta Crystallographica Section C (2011) 67, 5 o179-o187
a=7.8763(13)Å b=9.6078(17)Å c=12.3115(19)Å
α=108.780(13)° β=95.194(13)° γ=99.959(13)°
2,6-diaminopyrimidin-4-one <i>N</i>-methyl-2-pyrrolidone solvate (3/2)
2(C4H6N4O),3(C5H9NO)
Acta Crystallographica Section C (2011) 67, 5 o179-o187
a=8.4550(9)Å b=10.0803(9)Å c=17.0735(15)Å
α=75.558(7)° β=78.222(8)° γ=81.363(8)°
2,6-diaminopyrimidin-4-one dimethylacetamide solvate (1/1)
C4H6N4O,C4H9NO
Acta Crystallographica Section C (2011) 67, 5 o179-o187
a=19.1494(13)Å b=7.8704(4)Å c=14.9104(11)Å
α=90.00° β=104.868(6)° γ=90.00°
2-amino-6-methylpyrimidin-4(3<i>H</i>)-one—–2-amino-6-methylpyrimidin-\ 4(1<i>H</i>)-one—–<i>N</i>-methyl-2-pyrrolidone (1/1/1)
2(C5H7N3O),C5H9NO
Acta Crystallographica Section C (2011) 67, 5 o179-o187
a=7.3321(7)Å b=9.8805(9)Å c=12.5860(12)Å
α=102.835(7)° β=98.830(8)° γ=91.555(8)°
3-Cyano-6-hydroxy-4-methyl-2-pyridone dimethyl sulfoxide monosolvate
C7H6N2O2,C2H6OS
Acta Crystallographica Section C Structural Chemistry (2015) 71, 1
a=5.3065(8)Å b=8.4460(14)Å c=12.1459(19)Å
α=91.810(13)° β=92.977(13)° γ=94.585(13)°
3-Cyano-6-hydroxy-4-methyl-2-pyridone <i>N</i>,<i>N</i>-dimethylacetamide monosolvate
C7H6N2O2,C4H9NO
Acta Crystallographica Section C Structural Chemistry (2015) 71, 1
a=7.1268(14)Å b=7.5481(13)Å c=12.774(2)Å
α=89.486(13)° β=75.620(14)° γ=65.679(13)°
2-Amino-4-dimethylamino-6-methylpyrimidin-1-ium 5-cyano-4-methyl-6-oxo-1,6-dihydropyridin-2-olate
C7H13N4,C7H5N2O2
Acta Crystallographica Section C Structural Chemistry (2015) 71, 1
a=7.1928(6)Å b=8.1316(7)Å c=13.6009(11)Å
α=93.219(7)° β=99.114(7)° γ=108.395(6)°
2,6-Diamino-4-dimethylamino-1,3,5-triazin-1-ium 5-cyano-4-methyl-6-oxo-1,6-dihydropyridin-2-olate--<i>N</i>,<i>N</i>-dimethylacetamide (1/1)
C5H11N6,C7H5N2O2,C4H9NO
Acta Crystallographica Section C Structural Chemistry (2015) 71, 1
a=7.6590(6)Å b=10.2703(8)Å c=13.9231(11)Å
α=105.134(6)° β=104.921(6)° γ=98.267(6)°
6-Aminouracil dimethylacetamide monosolvate
C4H5N3O2,C4H9NO
Acta Crystallographica Section C (2013) 69, 11 1402-1407
a=7.5434(6)Å b=13.0020(14)Å c=10.5130(9)Å
α=90.00° β=92.728(7)° γ=90.00°
6-Aminouracil dimethylacetamide monosolvate
C4H5N3O2,C4H9NO
Acta Crystallographica Section C (2013) 69, 11 1402-1407
a=7.1200(7)Å b=21.882(3)Å c=13.1561(14)Å
α=90.00° β=92.908(8)° γ=90.00°
6-Aminouracil 1-methylpyrrolidin-2-one monosolvate
C4H5N3O2,C5H9NO
Acta Crystallographica Section C (2013) 69, 11 1402-1407
a=7.5767(14)Å b=21.889(3)Å c=7.1356(11)Å
α=90.00° β=117.312(12)° γ=90.00°
Hydantoin-5-acetic acid
C5H6N2O4
Acta Crystallographica Section C (2012) 68, 2 o92-o98
a=7.6148(5)Å b=8.5592(6)Å c=9.3406(6)Å
α=90.00° β=90.00° γ=90.00°
Orotic acid dimethyl sulfoxide monosolvate
C5H4N2O4,C2H6OS
Acta Crystallographica Section C (2012) 68, 2 o92-o98
a=9.3710(6)Å b=5.9752(3)Å c=17.8433(13)Å
α=90.00° β=97.447(6)° γ=90.00°
Dimethylammonium orotate--orotic acid (1/1)
C2H8N,C5H3N2O4,C5H4N2O4
Acta Crystallographica Section C (2012) 68, 2 o92-o98
a=8.1110(10)Å b=8.9503(11)Å c=11.6804(15)Å
α=112.366(3)° β=97.263(2)° γ=104.621(2)°
Dimethylammonium orotate--orotic acid (3/1)
3(C2H8N),3(C5H3N2O4),C5H4N2O4
Acta Crystallographica Section C (2012) 68, 2 o92-o98
a=7.0176(14)Å b=18.026(4)Å c=12.906(3)Å
α=90.00° β=94.94(3)° γ=90.00°
2,6-diaminopyrimidin-4-one dimethylformamide solvate hydrate (3/4/1)
(C4H6N4O),4/3(C3H7NO),1/3(H2O)
Acta Crystallographica Section C (2011) 67, 5 o179-o187
a=7.4417(6)Å b=25.3217(18)Å c=9.8578(7)Å
α=90.00° β=108.476(6)° γ=90.00°